BRAF V600E
Clinical trials for BRAF V600E explained in plain language.
Never miss a new study
Get alerted when new BRAF V600E trials appear
Sign up with your email to follow new studies for BRAF V600E, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo shows promise for Tough-to-Treat colorectal cancer
Disease control CompletedThis study tested a new two-drug combination (encorafenib and cetuximab) against standard treatments in 107 Chinese patients with a specific genetic mutation (BRAF V600E) that makes colorectal cancer harder to treat. The goal was to see if the new combo could slow cancer growth b…
Matched conditions: BRAF V600E
Phase: PHASE2 • Sponsor: Pierre Fabre Medicament • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC
-
New drug cocktail shows promise in rare colorectal cancer
Disease control CompletedThis study tested a combination of three drugs (encorafenib, binimetinib, and cetuximab) given before surgery to people with a specific type of colorectal cancer that has a BRAF V600E mutation. Only 2 patients took part. The goal was to see how much the tumor shrank and to check …
Matched conditions: BRAF V600E
Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated Jun 18, 2026 11:50 UTC